Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongtai City Spirulina Bio-Engineering is a Chinese microalgae and nutraceutical manufacturer focused on the research, cultivation, processing, and commercial sale of spirulina- and chlorella-based health food ingredients and finished products. The company markets products such as spirulina powder, chlorella powder, tablets, organic variants, and phycocyanin, and appears to operate at full commercial scale rather than as a drug-development biotech. It states that it has a large production base in Dongtai, Jiangsu and exports to more than 30 countries and regions. The company also describes collaborations with Chinese Academy of Sciences-affiliated institutes on higher-end microalgae technologies including phycocyanin, polysaccharides, and microalgae-related applications. Overall, this is best characterized as a commercial microalgae health-ingredients and manufacturing company within the broader health and life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongtai City Spirulina Bio-Engineering.